Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma

Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma

The plasma cell proliferative disorders monoclonal gammopathy of undetermined significance (MGUS) and malignant multiple myeloma (MM) are characterized by an accumulation of transformed clonal plasma cells in the bone marrow and production of monoclonal immunoglobulin. They typically affect an older...

Full description

Bibliographic Details
Main Authors:	Sarah eTete, Marc eBijl, Surinder eSahota, Nicolaas Adrianus Bos
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-06-01
Series:	Frontiers in Immunology
Subjects:	Multiple Myeloma Vaccination Infections MGUS immune defects
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00257/full

Similar Items

Progression patterns in monoclonal gammopathy of undetermined significance and multiple myeloma outcome: a cohort study in 42 patients
by: Widad Tahiru, et al.
Published: (2022-02-01)

Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
by: Oliver C. Lomas, et al.
Published: (2020-06-01)

The “Undetermined Significance” of <sup>18</sup>F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
by: Giorgio Treglia, et al.
Published: (2021-08-01)

Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
by: Daniela Damasceno, et al.
Published: (2021-03-01)

Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies
by: Ivana Lagreca, et al.
Published: (2023-02-01)

Low knowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among general practitioners
by: Charlene M. McShane, et al.
Published: (2019-05-01)

Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies
by: Vanessa Innao, et al.
Published: (2021-05-01)

Geographic Prevalence Patterns and Modifiable Risk Factors for Monoclonal Gammopathy of Undetermined Significance
by: Karina P. Verma, et al.
Published: (2023-11-01)

Monoclonal Gammopathy of Undetermined Cardiovascular Significance; Current Evidence and Novel Insights
by: Anastasios Tentolouris, et al.
Published: (2023-12-01)

The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches
by: Ivana Lagreca, et al.
Published: (2022-05-01)

A case of benign immunoglobulin D monoclonal gammopathy of undetermined significance with 26 years of follow‐up
by: Larry D. Anderson Jr., et al.
Published: (2024-02-01)

Identifying monoclonal gammopathy of undetermined significance from electronic health records
by: Hilary C. Tanenbaum, et al.
Published: (2023-03-01)

Outcomes of Patients with Monoclonal Gammopathy of Undetermined Significance with and without Atrial Fibrillation: A Retrospective Cohort Analysis of the Nationwide Inpatient Sample Database
by: Rachelle Hamadi, et al.
Published: (2023-06-01)

Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple Myeloma
by: Bastien Jamet, et al.
Published: (2020-02-01)

Treatment of Patients with Monoclonal Gammopathy of Clinical Significance
by: David F. Moreno, et al.
Published: (2021-10-01)

Refractory immune thrombocytopenic purpura associated with IgM monoclonal gammopathy of undetermined significance: Successful treatment with tirabrutinib plus conventional therapies
by: Ryosuke Naka, et al.
Published: (2022-05-01)

Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens
by: Jean Harb, et al.
Published: (2021-02-01)

A rare case of schizophrenia coexistence with antiphospholipid syndrome, β-thalassemia, and monoclonal gammopathy of undetermined significance
by: Yingming Jin, et al.
Published: (2023-04-01)

Accuracy and Reliability of Internet Resources for Information on Monoclonal Gammopathy of Undetermined Significance—What Information Is out There for Our Patients?
by: Emma Pauline Kreutzer, et al.
Published: (2021-09-01)

Penile Tuberculosis Associated with Monoclonal Gammopathy of Undetermined Significance
by: Wilfred C.H. Wu, et al.
Published: (2006-01-01)

Monoclonal gammopathy of undetermined significance-associated scleromyxoedema
by: Kalgi D Baxi, et al.
Published: (2019-01-01)

Scleroderma Associated with Monoclonal Gammopathy of Undetermined Significance
by: Dalya M. M. Abdelmaged, et al.
Published: (2022-12-01)

Molecular Pathways Engaged by Immunomodulatory Agents in Monoclonal Gammopathy-Associated Pure Red Cell Aplasia Rescue
by: Rakesh Verma
Published: (2020-08-01)

Nutritional Status Indices and Monoclonal Gammopathy of Undetermined Significance Risk in the Elderly Population: Findings from the National Health and Nutrition Examination Survey
by: Linfeng Li, et al.
Published: (2023-09-01)

The role of bone marrow microenvironment in the progression of multiple myeloma from monoclonal gammopathy of undetermined significance
by: A. S. Khudovekova, et al.
Published: (2021-09-01)

Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia
by: Monique A Hartley-Brown, et al.
Published: (2010-02-01)

Non-secretory immunoglobulin E myeloma associated with immunoglobulin G monoclonal gammopathy of undetermined significance
by: Masako Yasuyama, et al.
Published: (2012-07-01)

Humoral immune response after anti-SARS-CoV-2 vaccine “booster” dose in patients with monoclonal gammopathy of undetermined significance (MGUS)
by: NICOLA SGHERZA, et al.
Published: (2023-01-01)

The yin–yang effects of immunity: From monoclonal gammopathy of undetermined significance to multiple myeloma
by: Zhigang Yi, et al.
Published: (2022-07-01)

Analysis of thymidine kinase serum levels by novel method DiviTum™ in multiple myeloma and monoclonal gammopathy of undetermined significance - comparison with imaging methods 99mTc-MIBI scintigraphy and 18F-FDG PET/CT
by: Jaroslav Bacovsky, et al.
Published: (2015-03-01)

Editorial: The Role of Microorganisms in Multiple Myeloma
by: Maria Linares, et al.
Published: (2022-06-01)

Distinct Nuclear Organization of Telomeres and Centromeres in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
by: Pak Lok Ivan Yu, et al.
Published: (2019-07-01)

Predictive Immune Markers for Disease Progression in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
by: İrem Şahver İşgör, et al.
Published: (2022-11-01)

Acquired von Willebrand syndrome in a patient with monoclonal gammopathy of unknown significance: A case report
by: Garima Gupta, et al.
Published: (2024-02-01)

Case Report: Monoclonal Gammopathies of Clinical Significance-Associated Myopathy: A Case-Based Review
by: Hongbin Yu, et al.
Published: (2022-07-01)

Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance: a genome-wide genetic interaction study
by: Subhayan Chattopadhyay, et al.
Published: (2018-06-01)

Game of Bones: How Myeloma Manipulates Its Microenvironment
by: Tyler Moser-Katz, et al.
Published: (2021-02-01)

Characterization of monoclonal gammopathy of undetermined significance progression to multiple myeloma through meta-analysis of GEO data
by: Jihad Aljabban, et al.
Published: (2023-07-01)

Apoptotic machinery diversity in Multiple Myeloma molecular subtypes.
by: Patricia eGomez-Bougie, et al.
Published: (2013-12-01)

Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins
by: Adrien Bosseboeuf, et al.
Published: (2017-10-01)